Canada markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
33.23-1.18 (-3.43%)
At close: 04:00PM EST
33.23 0.00 (0.00%)
After hours: 04:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.45B
Enterprise Value 4.83B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)9.03
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -15.74

Trading Information

Stock Price History

Beta (5Y Monthly) 1.44
52-Week Change 313.34%
S&P500 52-Week Change 3-9.23%
52 Week High 341.46
52 Week Low 319.86
50-Day Moving Average 330.67
200-Day Moving Average 328.91

Share Statistics

Avg Vol (3 month) 3524.39k
Avg Vol (10 day) 3386.42k
Shares Outstanding 5156.32M
Implied Shares Outstanding 6N/A
Float 868.1M
% Held by Insiders 117.59%
% Held by Institutions 186.13%
Shares Short (Jan 12, 2023) 45.29M
Short Ratio (Jan 12, 2023) 47.91
Short % of Float (Jan 12, 2023) 411.41%
Short % of Shares Outstanding (Jan 12, 2023) 43.38%
Shares Short (prior month Dec 14, 2022) 44.8M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-22.24%
Return on Equity (ttm)-51.57%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -320.4M
Net Income Avi to Common (ttm)-317.76M
Diluted EPS (ttm)-1.71
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)989.92M
Total Cash Per Share (mrq)6.34
Total Debt (mrq)433.11M
Total Debt/Equity (mrq)71.78
Current Ratio (mrq)16.64
Book Value Per Share (mrq)3.86

Cash Flow Statement

Operating Cash Flow (ttm)-258.45M
Levered Free Cash Flow (ttm)-143.59M